PharmaShots | Incisive News in 3 Shots

Subscribe Now

ARTHEx Biotech

The US FDA Clears ARTHEx Biotech’s IND Application to Commence the P-I-IIa (ArthemiR) Study of ATX-01 for Myotonic Dystrophy Type 1 (DM1)

The US FDA Clears ARTHEx Biotech’s IND Application to Commence the P-I-IIa (ArthemiR) Study of ATX-01 for Myotonic Dystrophy Type...

February 28, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us